Skip to content

Esmketamine for profound and moderate sedation in pediatric patients.

Esmketamine for profound and moderate sedation in pediatric patients.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088919
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatient Child sedation

Interventions

dex group:Dexmedetomidine 3ug/kg intranasal
desk group:Dexmedetomidine 2ug/kg+ esketamine 1mg/ml intranasal

Sponsors

Maternal and Child Health Hospital of Hubei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: (1) American Society of Anesthesiologists (ASA) grade ?-?; (2) Children aged 0-5 years old; (3) There were no gender restrictions for the subjects; (4) No recent history of sedative usage; (5) Body mass index (BMI) less than 25; (6) No history of mental illness; (7) Legal guardians must provide informed consent for sedation.

Exclusion criteria

Exclusion criteria: 1) The family members of the children declined to provide informed consent for their participation in the trial. 2) Previous history of allergy to narcotic drugs, active ingredients, and excipients is present. 3) Patients with severe congenital heart disease and abnormal liver and kidney function are excluded. 4) Children with gastroesophageal reflux are not eligible for inclusion. 5) The presence of conscious disturbance is considered an exclusion criterion. 6) A history of nervous system disorders and mental illness is taken into account as an exclusion factor. 7) Individuals at serious risk of elevated blood pressure or intracranial pressure are excluded from the study.

Design outcomes

Primary

MeasureTime frame
heart rate;oxygen saturation;blood pressure;

Countries

China

Contacts

Public ContactJing Cheng

Maternal and Child Health Hospital of Hubei Province

21320774@qq.com+86 189 0865 7384

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026